Tag: Valve Disease

ENBALV: Edoxaban or warfarin as anticoagulant after bioprosthetic valve replacement?

Presented By
Dr Chisato Izumi, National Cerebral and Cardiovascular Center, Japan
Trial
Phase 3, ENBALV
Conference
AHA 2024
Type
Peer-reviewed article

3 February 2025 15:00

POPular TAVI: Aspirin-only antiplatelet strategy?

Presented By
Dr Jorn Brouwer, St Antonius Hospital, the Netherlands
Trial
POPular TAVI trial
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 13:28

TAVR safe and effective in low-risk bicuspid aortic stenosis patients

Presented By
Dr B. Ramlawi, Valley Health System, USA
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 13:22

TAVR model reveals differences in hospital outcomes

Presented By
Dr N. Desai, Hospital of the University of Pennsylvania, USA
Trial
STS/ACC TVT Registry
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 13:12

TAVR versus surgery in older patients

Presented By
Dr W. Toff, University of Leicester, UK
Trial
UK TAVI
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 13:08

Real-world evidence for MitraClip

Presented By
Dr S. Lim, University of Virginia, USA
Trial
EXPAND G4
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 13:03

2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis

Presented By
Prof. M. Mack, Baylor Scott & White Heart Hospital, USA
Trial
PARTNER 3
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 12:58

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

Presented By
Dr G.R. Hong, Yonsei University College of Medicine, South Korea
Trial
ENAVLE
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:15

Full GALILEO results: Why did rivaroxaban fail after TAVR?

Presented By
Prof. George Dangas, Icahn School of Medicine at Mount Sinai, USA
Trial
GALILEO
Conference
AHA 2019

26 February 2020 20:28
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com